Loading fund overlap…
15 of 119 unique stocks in common · Jaccard: 12.6%
A weighted portfolio overlap of 15.24% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹15.24 is allocated to the exact same companies at the same relative proportions. The schemes share 15 common holdings.
The largest overlapping asset in their portfolios is Infosys, which commands a weight of 6.00% in ICICI Prudential India Opportunities Fund and 2.34% in UTI - MNC Fund. Holding both schemes increases your concentration in Infosys rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in ICICI | in UTI |
|---|---|---|
| InfosysIT - Software | 6.00% | 2.34% |
| Hindustan UnileverDiversified FMCG | 2.01% | 5.30% |
| Britannia IndustriesFood Products | 1.81% | 2.66% |
| Gland PharmaPharmaceuticals & Biotechnology | 1.80% | 3.56% |
| Tata Consultancy ServicesIT - Software | 1.74% | 1.86% |
| Tata CommunicationsTelecom - Services | 1.23% | 1.28% |
| CoforgeIT - Software | 1.56% | 1.20% |
| Affle 3iIT - Services | 0.77% | 1.82% |
| Aurobindo PharmaPharmaceuticals & Biotechnology | 0.73% | 1.32% |
| MphasisIT - Software | 0.35% | 0.42% |
| Maruti Suzuki IndiaAutomobiles | 0.32% | 8.52% |
| VedantaDiversified Metals | 0.31% | 0.53% |
| Cohance LifesciencesPharmaceuticals & Biotechnology | 0.28% | 0.62% |
| CIE Automotive IndiaAuto Components | 0.28% | 1.69% |
| Samvardhana Motherson InternationalAuto Components | 0.06% | 1.30% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.